Reports for SANIS HEALTH INC
Company Name
SANIS HEALTH INC
Totals |
||
Shortage reports |
636 |
|
| Actual shortage: | 62 (10%) | |
| Anticipated shortage: | 1 (0%) | |
| Avoided shortage: | 16 (3%) | |
| Resolved: | 557 (88%) | |
Discontinuation Reports |
72 |
|
| To be discontinued: | 7 (10%) | |
| Discontinued: | 54 (75%) | |
| Reversed: | 11 (15%) | |
Late reports |
52 (7%) |
|
Overdue reports |
20 (29%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| CANDESARTAN | 32MG | TABLET | Resolved | 2019-01-25 | 2019-04-24 | 73520 |
| CANDESARTAN | 16MG | TABLET | Resolved | 2019-04-09 | 2019-05-16 | 80863 |
| CANDESARTAN | 4MG | TABLET | Resolved | 2019-06-19 | 2019-07-06 | 87077 |
| CANDESARTAN | 4MG | TABLET | Resolved | 2019-10-21 | 2020-01-04 | 96874 |
| CANDESARTAN | 8MG | TABLET | Resolved | 2019-10-21 | 2020-01-04 | 96880 |
| CANDESARTAN | 32MG | TABLET | Resolved | 2019-10-21 | 2020-02-13 | 96884 |
| CANDESARTAN | 16MG | TABLET | Resolved | 2019-11-21 | 2020-05-28 | 99480 |
| CANDESARTAN | 4MG | TABLET | Resolved | 2020-02-27 | 2020-03-27 | 107296 |
| CANDESARTAN | 8MG | TABLET | Resolved | 2020-02-27 | 2020-05-12 | 107299 |
| CANDESARTAN | 32MG | TABLET | Resolved | 2020-03-26 | 2020-04-01 | 109439 |
| CANDESARTAN | 8MG | TABLET | Resolved | 2020-05-11 | 2020-10-21 | 114758 |
| CANDESARTAN | 16MG | TABLET | Resolved | 2023-07-17 | 2023-09-05 | 198795 |
| CANDESARTAN | 4MG | TABLET | Resolved | 2023-07-18 | 2023-11-06 | 198936 |
| CANDESARTAN | 32MG | TABLET | Resolved | 2023-10-23 | 2024-03-11 | 207878 |
| CANDESARTAN | 4MG | TABLET | Resolved | 2023-11-22 | 2023-12-26 | 211086 |
| CANDESARTAN | 16MG | TABLET | Resolved | 2024-01-17 | 2024-08-15 | 216273 |
| CANDESARTAN | 8MG | TABLET | Resolved | 2024-01-30 | 2024-04-23 | 217790 |
| CANDESARTAN | 16MG | TABLET | Resolved | 2024-02-26 | 2024-04-23 | 220656 |
| CANDESARTAN | 4MG | TABLET | Actual shortage | 2024-04-09 | 2024-08-29 | 224727 |
| CANDESARTAN | 8MG | TABLET | Resolved | 2024-05-28 | 2024-07-16 | 228960 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| INDAPAMIDE | 1.25MG | TABLET | Discontinued | 2017-03-14 | 2017-03-14 | 2453 |
| LORAZEPAM | 0.5MG | TABLET | Reversed | 2017-03-14 | 2017-07-31 | 2430 |
| LORAZEPAM | Discontinued | 2020-02-27 | 2020-02-27 | 107347 | ||
| LORAZEPAM | 1.0MG | TABLET | Discontinued | 2021-05-17 | 2021-11-16 | 139511 |
| LORAZEPAM | 2.0MG | TABLET | Discontinued | 2021-08-12 | 2022-02-06 | 144029 |
| LORAZEPAM | 2.0MG | TABLET | Discontinued | 2021-12-16 | 2021-12-17 | 151293 |
| MINOCYCLINE | Discontinued | 2019-01-22 | 2019-01-22 | 73236 | ||
| MINOCYCLINE | Discontinued | 2019-01-22 | 2019-01-22 | 73239 | ||
| MORPHINE SR | 15MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2020-04-08 | 2020-06-13 | 111515 |
| MORPHINE SR | 30MG | TABLET (EXTENDED-RELEASE) | To be discontinued | 2020-04-08 | 2020-04-08 | 111518 |
| MORPHINE SR | 60MG | TABLET (EXTENDED-RELEASE) | To be discontinued | 2020-04-08 | 2020-06-03 | 111521 |
| OXYBUTYNIN | 5MG | TABLET | Discontinued | 2025-08-11 | 2025-10-12 | 264958 |
| OXYBUTYNIN | 5MG | TABLET | Discontinued | 2025-08-11 | 2025-08-12 | 264961 |
| OXYCODONE/ACET | 5MG 325MG | TABLET | Discontinued | 2020-04-08 | 2020-06-09 | 111527 |
| OXYCODONE/ACET | 5MG 325MG | TABLET | Discontinued | 2020-04-08 | 2020-06-09 | 111531 |
| PANTOPRAZOLE T | 40MG | TABLET (DELAYED-RELEASE) | Discontinued | 2025-10-27 | 2025-10-28 | 270365 |
| PRAMIPEXOLE | 0.25MG | TABLET | Discontinued | 2019-03-26 | 2019-03-27 | 79465 |
| PRAMIPEXOLE | 0.5MG | TABLET | Discontinued | 2019-03-26 | 2019-03-27 | 79468 |
| PRAMIPEXOLE | 1MG | TABLET | Discontinued | 2019-03-26 | 2019-03-27 | 79471 |
| RAMIPRIL-HCTZ | 12.5MG 10.0MG | TABLET | Discontinued | 2017-03-16 | 2017-03-16 | 3023 |